Trial
NCT06768658
A Study of TAK-951 in Participants With Cyclic Vomiting Syndrome (CVS)
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Takeda
Collaborators
—
Condition
Nausea and Vomitting
Intervention
TAK-951
Why stopped
Due to business reasons prior to first subject dosed.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-07-02